Matthew Reardon

Matt advises the management and boards of directors of a range of innovative companies in the technology and life sciences industries in general business and corporate matters, including Axim Collaborative (a nonprofit focused on education led by Harvard University and Massachusetts Institute of Technology), Emporia Technology Holdings, HYCU, Invicti Security, Keylicon Biosciences, Landmark Bio, Mercy Bioanalytics, THINKMD, Toppings, and Weaviate.

• edX Inc. in its strategic transaction with 2U, Inc.
• Fleetmatics Group PLC in its $2.4 billion sale to Verizon
• AppNexus in its sale to AT&T
• 6 River Systems, Inc. in its $450 million sale to Shopify Inc.
• Boston Dynamics in its acquisition by Google, Inc.
• Landmark Bio, PBLLC in a public benefit joint venture formation between Harvard University, Massachusetts Institute of Technology, Fujifilm Diosynth Biotechnologies, Cytiva, and Alexandria Real Estate Equities
• New Euro-Pro Holdings LLC (d/b/a “SharkNinja”) in an investment by CDH Investments
• PTC Inc. in its acquisition of Enigma
• Continuum Managed Services in its sale to Thoma Bravo, and subsequent sale to ConnectWise, LLC.
• Continuum Managed Services in its acquisitions of BrightGauge Software Inc. and Carvir, LLC
• Evariant, Inc., in its sale to Healthgrades
• Virex Health in its acquisition by Sorrento Therapeutics, Inc.
• Hypnos Capital in its acquisition of Napster
• ANSYS, Inc. in its investment in 3DSIM, LLC
• Braemar Energy Ventures in its sale of a portfolio company
• BATON Financial Services in its sale to TreviPay
• Nova Ventures Group in its acquisitions of multiple portfolio companies in the sensors industry
• Alkermes plc. in its $50 million sale of a division to Recro Pharma, Inc.
• GnuBio Inc. in its sale to Bio-Rad Laboratories, Inc.
• Viracor-IBT in its $255 million sale to Eurofins Scientific
• Essilor International in its acquisition of Costa Inc.
• Perfumania Holdings, Inc. in its acquisition of Parlux Fragrances, Inc.

• Bessemer Venture Partners in investments in early-stage technology companies
• General Catalyst Partners in investments in entrepreneur-in-residence investment vehicles
• Matrix Partners in investments in early-stage technology companies
• Optum Venture Partners in investments in portfolio companies
• The investment funds of a large financial services firm in their investments in a wide range of fintech, disruptive sciences, and consumer goods portfolio companies
• Bison Ventures in investments in portfolio companies
• Will Ventures in investments in portfolio companies at the intersection of sports and technology
• BioInnovation Capital in investments in early-stage life sciences companies
• Romulus Capital in investments in Ceres Imaging, Cogito, Cohealo, Disruptor Beam, E la Carte, EquipmentShare.com, Humanyze, Petagene, Placester, and Vyome Biosciences
• Flare Capital Partners in its investment in Bright Health
• Ascension Ventures in its investments in Atigeo, Inc. and Syapse, Inc.
• Alkermes plc in its investment in ReSet Therapeutics, Inc.
• Asahi Kasei Corporation in its investment in Hydro-Photon, Inc.
• Mercy BioAnalytics, Inc. in its preferred equity financings
• Weaviate, Inc. in its preferred equity financings
• BATON Financial Services in its preferred equity financings
• Startup Institute in its Series B equity financing
• Open Door Trading LLC in its equity financings
• THINKMD, PBC in its equity financings
• Serenity Pharmaceuticals LLC in its Series C equity financing
• Viamet Pharmaceuticals in its Series C equity financing